ResMed Inc. Common Stock (NY:RMD)

ResMed is a leader in CPAP machines and other medical devices that help millions breathe better.

Topics Economy

3 Reasons Not to Sleep on ResMed Stock ↗

March 10, 2026

Via The Motley Fool

3 Healthcare Stocks to Target This Week

March 09, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se...

Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

March 03, 2026

Center to Create Local Jobs and Strengthen U.S. Healthcare Supply Resilience

ResMed Inc (NYSE:RMD): A Durable Dividend Stock Built on Financial Strength ↗

February 26, 2026

Via Chartmill

ResMed Inc. (NYSE:RMD) Emerges as a Prime Quality Investing Candidate ↗

February 23, 2026

Via Chartmill

ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion ↗

January 29, 2026

Via Chartmill

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 24, 2026

Via Chartmill

Top S&P500 movers in Tuesday's session ↗

February 24, 2026

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

February 24, 2026

Via Chartmill

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

February 24, 2026

Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below the S&P 500’s 5.9% gain. This might have investors contemplating their next...

ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?

February 15, 2026

Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that generate even more profits, creating a virtuous...

Topics Stocks

ResMed Inc (NYSE:RMD) Stands Out as a High-Quality Dividend Stock ↗

January 29, 2026

Via Chartmill

ResMed Inc. (NYSE:RMD) Embodies Quality Investing Principles ↗

January 16, 2026

Via Chartmill

3 Quality Compounders to Consider Right Now

February 11, 2026

ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in its...

The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call

February 05, 2026

Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share...

Topics Earnings Economy

RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth

January 30, 2026

ResMed (RMD) Q2 2026 Earnings Call Transcript

Topics Economy

ResMed (RMD) Q2 2026 Earnings Call Transcript ↗

January 29, 2026

Via The Motley Fool

Topics Artificial Intelligence Earnings

ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations

January 29, 2026

Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share was 3.2% above...

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

January 29, 2026

Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what you need to know.

ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect

January 27, 2026

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

1 Safe-and-Steady Stock Worth Investigating and 2 We Find Risky

January 25, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers.

Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)

January 14, 2026

Beyond the ZZZs: Stanford’s SleepFM Turns a Single Night’s Rest into a Diagnostic Powerhouse

Topics Artificial Intelligence

January 14, 2026

In a landmark shift for preventative medicine, researchers at Stanford University have unveiled SleepFM, a pioneering multimodal AI foundation model capable of predicting over 130 different health...

Via TokenRing AI

Topics Artificial Intelligence

ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?

January 13, 2026

Since July 2025, ResMed has been in a holding pattern, floating around $254.41. The stock also fell short of the S&P 500’s 11.3% gain during that period.

Topics Stocks

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

January 08, 2026

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid

December 28, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

December 21, 2025

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

December 18, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

December 16, 2025